These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 1318677)

  • 21. In-vitro activity of fleroxacin against Chlamydia trachomatis.
    Steele-Mortimer O; Meier-Ewert H
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():65-70. PubMed ID: 3144551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-vitro activity of azithromycin, erythromycin, ciprofloxacin and norfloxacin against Neisseria gonorrhoeae, Haemophilus ducreyi, and Chlamydia trachomatis.
    Slaney L; Chubb H; Ronald A; Brunham R
    J Antimicrob Chemother; 1990 Jan; 25 Suppl A():1-5. PubMed ID: 2154426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro assays of the efficacy of antimicrobial agents in controlling Chlamydia trachomatis propagation.
    Lee CK; Bowie WR; Alexander ER
    Antimicrob Agents Chemother; 1978 Mar; 13(3):441-5. PubMed ID: 162541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of azithromycin and tetracycline against 358 clinical isolates of Brucella melitensis.
    Landínez R; Liñares J; Loza E; Martínez-Beltrán J; Martín R; Baquero F
    Eur J Clin Microbiol Infect Dis; 1992 Mar; 11(3):265-7. PubMed ID: 1317801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of sustained antibiotic bactericidal treatment on Chlamydia trachomatis-infected epithelial-like cells (HeLa) and monocyte-like cells (THP-1 and U-937).
    Mpiga P; Ravaoarinoro M
    Int J Antimicrob Agents; 2006 Apr; 27(4):316-24. PubMed ID: 16527461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the in vitro activities of ofloxacin and tetracycline against Chlamydia trachomatis as assessed by indirect immunofluorescence.
    Bailey JM; Heppleston C; Richmond SJ
    Antimicrob Agents Chemother; 1984 Jul; 26(1):13-6. PubMed ID: 6383207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of the in vitro susceptibility of clinical isolates of chlamydia trachomatis with serovar and duration of antibiotic exposure.
    Zheng H; Xue Y; Bai S; Qin X; Lu P; Yang B
    Sex Transm Dis; 2015 Mar; 42(3):115-9. PubMed ID: 25668641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chlamydia trachomatis genitourinary infections: laboratory diagnosis and therapeutic aspects. Evaluation of in vitro and in vivo effectiveness of azithromycin.
    Chiarini F; Mansi A; Tomao P; Gentile V; De Marco F; Brunori S; Wongher L; Di Silverio F
    J Chemother; 1994 Aug; 6(4):238-42. PubMed ID: 7830100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chlamydia trachomatis antimicrobial susceptibility in colorectal and endocervical cells.
    Foschi C; Salvo M; Cevenini R; Marangoni A
    J Antimicrob Chemother; 2018 Feb; 73(2):409-413. PubMed ID: 29077843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniae.
    Hammerschlag MR; Qumei KK; Roblin PM
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1573-4. PubMed ID: 1324650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of dirithromycin, a new macrolide antibiotic, against Mycoplasma species.
    Rennie KA; Prasad ES; Wenman WM
    Diagn Microbiol Infect Dis; 1994 Sep; 20(1):57-9. PubMed ID: 7867300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Susceptibility study on urogenital Chlamydia trachomatis to 19 kinds of antibiotics].
    Bai H; Dong J; Ning B
    Zhonghua Yi Xue Za Zhi; 1995 Jan; 75(1):11-4, 60. PubMed ID: 7600311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro comparison of the activity of doxycycline, tetracycline, erythromycin and a new macrolide, CP 62993, against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.
    Rylander M; Hallander HO
    Scand J Infect Dis Suppl; 1988; 53():12-7. PubMed ID: 2843982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In-vitro activity of azithromycin on Chlamydia trachomatis infected, polarized human endometrial epithelial cells.
    Wyrick PB; Davis CH; Knight ST; Choong J
    J Antimicrob Chemother; 1993 Jan; 31(1):139-50. PubMed ID: 8383102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activities of tetracycline & ciprofloxacin against Chlamydia trachomatis isolates from conjunctivitis patients.
    Madhavan HN; Roy S; Malathy J
    Indian J Med Res; 1996 Mar; 103():138-41. PubMed ID: 9062038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative in-vitro activity of moxifloxacin, minocycline and azithromycin against Chlamydia spp.
    Donati M; Rodrìguez Fermepin M; Olmo A; D'Apote L; Cevenini R
    J Antimicrob Chemother; 1999 Jun; 43(6):825-7. PubMed ID: 10404322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The in-vitro activity of clarithromycin and other macrolides against the type strain of Chlamydia pneumoniae (TWAR).
    Ridgway GL; Mumtaz G; Fenelon L
    J Antimicrob Chemother; 1991 Feb; 27 Suppl A():43-5. PubMed ID: 1827101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Partial characterization of Chlamydia trachomatis isolates resistant to multiple antibiotics.
    Jones RB; Van der Pol B; Martin DH; Shepard MK
    J Infect Dis; 1990 Dec; 162(6):1309-15. PubMed ID: 2230260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro drug susceptibility of Chlamydia sp. strain TWAR.
    Kuo CC; Grayston JT
    Antimicrob Agents Chemother; 1988 Feb; 32(2):257-8. PubMed ID: 2966609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of CEM-101, a new fluoroketolide antibiotic, against Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae.
    Roblin PM; Kohlhoff SA; Parker C; Hammerschlag MR
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1358-9. PubMed ID: 20038627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.